Literature DB >> 15573048

Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission.

Jon P Furuno1, Anthony D Harris, Marc-Oliver Wright, Jessina C McGregor, Richard A Venezia, Jingkun Zhu, Eli N Perencevich.   

Abstract

BACKGROUND: In 2003, the Society of Healthcare Epidemiology of America (SHEA) recommended surveillance cultures upon hospital admission for patients at high risk for carriage of vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). The aim of this study was to assess the validity of factors from past medical history in defining patients at high risk for subsequent positive cultures with VRE or MRSA upon hospital admission.
METHODS: Subjects were adult inpatients admitted to nonintensive care wards of the index hospital during 2001-2002. Cases had MRSA or VRE positive clinical cultures within 48 hours of hospital admission. Patients with previous history of MRSA or VRE were excluded.
RESULTS: Nineteen thousand three hundred ninety-nine patients were included, with 273 cases of VRE or MRSA. Previous admission within 1 year of current admission had a sensitivity of 56.8% and a specificity of 88.4% for predicting a case of MRSA or VRE. Individually, the sensitivity and specificity for admission within the past year were 50.5% and 88.4%, respectively, for MRSA and 76.9% and 88.4%, respectively, for VRE.
CONCLUSIONS: Patients with a previous hospital admission represent a high-risk population for positive culture for VRE and MRSA and may be a group of which active surveillance is indicated.

Entities:  

Mesh:

Year:  2004        PMID: 15573048     DOI: 10.1016/j.ajic.2004.03.009

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  11 in total

1.  Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.

Authors:  Anthony D Harris; Jon P Furuno; Mary-Claire Roghmann; Jennifer K Johnson; Laurie J Conway; Richard A Venezia; Harold C Standiford; Marin L Schweizer; Joan N Hebden; Anita C Moore; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

2.  Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Matteo Bassetti; Francesco Giuseppe De Rosa; Teresa Spanu; Eugenia Di Meco; Angela Raffaella Losito; Andrea Parisini; Nicole Pagani; Roberto Cauda
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

3.  Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia.

Authors:  Regina B Osih; Jessina C McGregor; Shayna E Rich; Anita C Moore; Jon P Furuno; Eli N Perencevich; Anthony D Harris
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

4.  Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission.

Authors:  Steven W Johnson; Deverick J Anderson; D Byron May; Richard H Drew
Journal:  Infect Control Hosp Epidemiol       Date:  2013-02-14       Impact factor: 3.254

5.  Risk of acquiring extended-spectrum β-lactamase-producing Klebsiella species and Escherichia coli from prior room occupants in the intensive care unit.

Authors:  Adebola O Ajao; J Kristie Johnson; Anthony D Harris; Min Zhan; Jessina C McGregor; Kerri A Thom; Jon P Furuno
Journal:  Infect Control Hosp Epidemiol       Date:  2013-05       Impact factor: 3.254

6.  Long-term care facilities: important participants of the acute care facility social network?

Authors:  Bruce Y Lee; Yeohan Song; Sarah M Bartsch; Diane S Kim; Ashima Singh; Taliser R Avery; Shawn T Brown; S Levent Yilmaz; Kim F Wong; Margaret A Potter; Donald S Burke; Richard Platt; Susan S Huang
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

7.  Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization.

Authors:  Jon P Furuno; Eli N Perencevich; Judith A Johnson; Marc-Oliver Wright; Jessina C McGregor; J Glenn Morris; Sandra M Strauss; Mary-Claire Roghman; Lucia L Nemoy; Harold C Standiford; Joan N Hebden; Anthony D Harris
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

8.  Variable performance of models for predicting methicillin-resistant Staphylococcus aureus carriage in European surgical wards.

Authors:  Andie S Lee; Angelo Pan; Stephan Harbarth; Andrea Patroni; Annie Chalfine; George L Daikos; Silvia Garilli; José Antonio Martínez; Ben S Cooper
Journal:  BMC Infect Dis       Date:  2015-02-27       Impact factor: 3.090

9.  Performance of an Easy and Simple New Scoring Model in Predicting Multidrug-Resistant Enterobacteriaceae in Community-Acquired Urinary Tract Infections.

Authors:  Houda Ben Ayed; Makram Koubaa; Fatma Hammami; Chakib Marrakchi; Khaoula Rekik; Tarak Ben Jemaa; Imed Maaloul; Sourour Yaich; Jamel Damak; Mounir Ben Jemaa
Journal:  Open Forum Infect Dis       Date:  2019-03-05       Impact factor: 3.835

10.  Pathogen transmission and clinic scheduling.

Authors:  John R Hotchkiss; David G Strike; Philip S Crooke
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.